YH ENT (02306) Drops Over 4% Again as Wang Yibo's Contract Renewal Concerns Weigh on Shares, Stock Down 40% from Yearly High

Stock News11-11

YH ENT (02306) fell over 4% again, with its shares now down more than 40% from this year's peak. At the time of writing, the stock dropped 4.37% to HK$1.97, with a trading volume of HK$2.72 million.

Market attention has turned to the renewal of Wang Yibo's contract after related hashtags like "Wang Yibo not renewing with YH ENT" trended on Weibo. According to reports, YH ENT's investor relations department stated, "His (Wang Yibo's) revenue contribution to the company is gradually declining, and his contract is originally set to expire next year. Please refer to our official announcement at that time."

Wang Yibo's contract with YH ENT is due to expire in October 2026, and any changes in their partnership are being closely watched. YH ENT's disclosures show that Wang Yibo contributed 16.8% of total revenue in 2019, but this figure rose to 59% in the first three quarters of 2022. In 2024, YH ENT reported total revenue of RMB765 million, with Wang Yibo accounting for RMB459 million, or over 60%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170538878?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 14:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170538878","market":"us","top_or_hot":-1,"title":"YH ENT (02306) Drops Over 4% Again as Wang Yibo's Contract Renewal Concerns Weigh on Shares, Stock Down 40% from Yearly High","media":"Stock News","content":"<p>YH ENT (02306) fell over 4% again, with its shares now down more than 40% from this year's peak. At the time of writing, the stock dropped 4.37% to HK$1.97, with a trading volume of HK$2.72 million.</p>\n<p>Market attention has turned to the renewal of Wang Yibo's contract after related hashtags like \"Wang Yibo not renewing with YH ENT\" trended on Weibo. According to reports, YH ENT's investor relations department stated, \"His (Wang Yibo's) revenue contribution to the company is gradually declining, and his contract is originally set to expire next year. Please refer to our official announcement at that time.\"</p>\n<p>Wang Yibo's contract with YH ENT is due to expire in October 2026, and any changes in their partnership are being closely watched. YH ENT's disclosures show that Wang Yibo contributed 16.8% of total revenue in 2019, but this figure rose to 59% in the first three quarters of 2022. In 2024, YH ENT reported total revenue of RMB765 million, with Wang Yibo accounting for RMB459 million, or over 60%.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YH ENT (02306) Drops Over 4% Again as Wang Yibo's Contract Renewal Concerns Weigh on Shares, Stock Down 40% from Yearly High</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYH ENT (02306) Drops Over 4% Again as Wang Yibo's Contract Renewal Concerns Weigh on Shares, Stock Down 40% from Yearly High\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-11 14:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YH ENT (02306) fell over 4% again, with its shares now down more than 40% from this year's peak. At the time of writing, the stock dropped 4.37% to HK$1.97, with a trading volume of HK$2.72 million.</p>\n<p>Market attention has turned to the renewal of Wang Yibo's contract after related hashtags like \"Wang Yibo not renewing with YH ENT\" trended on Weibo. According to reports, YH ENT's investor relations department stated, \"His (Wang Yibo's) revenue contribution to the company is gradually declining, and his contract is originally set to expire next year. Please refer to our official announcement at that time.\"</p>\n<p>Wang Yibo's contract with YH ENT is due to expire in October 2026, and any changes in their partnership are being closely watched. YH ENT's disclosures show that Wang Yibo contributed 16.8% of total revenue in 2019, but this figure rose to 59% in the first three quarters of 2022. In 2024, YH ENT reported total revenue of RMB765 million, with Wang Yibo accounting for RMB459 million, or over 60%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02306","symbol_name":"乐华娱乐","start_time":0,"source_url":"","article_id":"1170538878","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170538878","pubTimestamp":1762842015,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"YH ENT (02306) fell over 4% again, with its shares now down more than 40% from this year's peak. At the time of writing, the stock dropped 4.37% to HK$1.97, with a trading volume of HK$2.72 million....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02306":"乐华娱乐","BK1128":"电影和娱乐"},"translate_title":"王一博续约担忧令股价承压，YH ENT(02306)再度跌超4%，股价较年内高位跌40%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02306":1},"content_text":"YH ENT (02306) fell over 4% again, with its shares now down more than 40% from this year's peak. At the time of writing, the stock dropped 4.37% to HK$1.97, with a trading volume of HK$2.72 million.\nMarket attention has turned to the renewal of Wang Yibo's contract after related hashtags like \"Wang Yibo not renewing with YH ENT\" trended on Weibo. According to reports, YH ENT's investor relations department stated, \"His (Wang Yibo's) revenue contribution to the company is gradually declining, and his contract is originally set to expire next year. Please refer to our official announcement at that time.\"\nWang Yibo's contract with YH ENT is due to expire in October 2026, and any changes in their partnership are being closely watched. YH ENT's disclosures show that Wang Yibo contributed 16.8% of total revenue in 2019, but this figure rose to 59% in the first three quarters of 2022. In 2024, YH ENT reported total revenue of RMB765 million, with Wang Yibo accounting for RMB459 million, or over 60%.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170538878","isCrawlerRequest":true}